BridgeBio Pharma, Inc. (BBIO)
77.75
-0.42
(-0.54%)
USD |
NASDAQ |
Nov 13, 10:26
BridgeBio Pharma EPS Diluted (Quarterly) : -0.4234 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4234 |
| June 30, 2026 | -0.7775 |
| March 31, 2026 | -0.8422 |
| December 31, 2025 | -0.9964 |
| September 30, 2025 | -0.9525 |
| June 30, 2025 | -0.9548 |
| March 31, 2025 | -0.8805 |
| December 31, 2024 | -1.399 |
| September 30, 2024 | -0.8596 |
| June 30, 2024 | -0.3916 |
| March 31, 2024 | -0.1971 |
| December 31, 2023 | -0.9638 |
| September 30, 2023 | -1.084 |
| June 30, 2023 | -0.9836 |
| March 31, 2023 | -0.9182 |
| December 31, 2022 | -0.9213 |
| September 30, 2022 | -0.9284 |
| June 30, 2022 | -0.0672 |
| Date | Value |
|---|---|
| March 31, 2022 | -1.346 |
| December 31, 2021 | -1.013 |
| September 30, 2021 | -1.063 |
| June 30, 2021 | -0.6565 |
| March 31, 2021 | -1.176 |
| December 31, 2020 | -1.008 |
| September 30, 2020 | -0.9805 |
| June 30, 2020 | -1.034 |
| March 31, 2020 | -0.7797 |
| December 31, 2019 | -0.6242 |
| September 30, 2019 | -0.5123 |
| June 30, 2019 | -0.7101 |
| March 31, 2019 | -0.4974 |
| December 31, 2018 | -0.4448 |
| September 30, 2018 | -0.5152 |
| June 30, 2018 | -0.2604 |
| March 31, 2018 | -0.3031 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Ionis Pharmaceuticals, Inc. | -0.6617 |
| Pfizer Inc. | 0.5637 |
| Cytokinetics, Inc. | -1.367 |
| Vertex Pharmaceuticals, Inc. | 2.561 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.50M |
| Revenue (Quarterly) | 353.17M |
| Total Expenses (Quarterly) | 409.88M |
| Enterprise Value | 18.15B |
| Gross Profit Margin (Quarterly) | 94.11% |
| Profit Margin (Quarterly) | -17.13% |
| Earnings Yield | -3.91% |
| Normalized Earnings Yield | -3.930 |